You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NAMS Exercise Disclosure
Kooij Louise Frederika · SEC Form 4 · Filed Jul 22, 2026
Exercise
Calculated transaction value
$0
Kooij Louise Frederika Chief Accounting Officer
NAMS
Transaction date
Jul 20, 2026
Public filing date
Jul 22, 2026
Filing lag
Filed 2 days later
NAMS daily price context
Close on/before transaction
$29.67
Jul 20, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Option (right to buy) on Ordinary Shares
- Quantity / price
- 25,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-312387
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$4.38M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| New Amsterdam Pharma Co N.V. NAMS | Sale | Jul 20, 2026 | $92.43K |
| New Amsterdam Pharma Co N.V. NAMS | Exercise | Jul 20, 2026 | $893.6K |
| New Amsterdam Pharma Co N.V. NAMS | Sale | Jul 20, 2026 | $990.03K |
| New Amsterdam Pharma Co N.V. NAMS Current | Exercise | Jul 20, 2026 | $0 |
| New Amsterdam Pharma Co N.V. NAMS | Exercise | Jul 20, 2026 | $0 |
| New Amsterdam Pharma Co N.V. NAMS | Exercise | Jul 20, 2026 | $297.5K |
| New Amsterdam Pharma Co N.V. NAMS | Sale | Jul 20, 2026 | $2.1M |